Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
|Articles|January 23, 2002
SonoSite expands presence in Japan, Germany
Handheld ultrasound pioneer SonoSite announced Jan. 15 that it had received clearance from the Japanese Ministry of Health, Labor, and Welfare to market and distribute its SonoSite 180PLUS and the SonoHeart PLUS products. They are enhanced versions of
Advertisement
Handheld ultrasound pioneer SonoSite announced Jan. 15 that it had received clearance from the Japanese Ministry of Health, Labor, and Welfare to market and distribute its SonoSite 180PLUS and the SonoHeart PLUS products. They are enhanced versions of other SonoSite products already being sold in the Japanese marketplace by SonoSite in collaboration with Olympus Optical. A week earlier, SonoSite released details about the start of a direct sales operation in Germany. The newly formed SonoSite GmbH officially opened Jan. 2, following introduction of the company's handheld products at the November 2001 Medica meeting in Dusseldorf. Cornel Schoelgens has been recruited to manage German operations as well as distribution in Austria and Switzerland. Schoelgens is a 20-year veteran of the diagnostic imaging industry, having held positions with GE Medical Systems and Acuson. SonoSite has direct sales operations in the U.S., the U.K., France, and Germany. It will soon begin direct sales in Spain.
Advertisement
Related to this article
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
Catch up on the most-well viewed radiology content in September 2026.
The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.
For patients with localized prostate cancer, stereotactic body radiotherapy (SBRT) offered comparable freedom from biochemical/clinical failure at eight years and nearly 40 percent lower urinary incontinence in comparison to radical prostatectomy, according to research presented at the ASTRO conference.
Catch up on the most well-viewed video interviews from Diagnostic Imaging in September 2026.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Radiology and Building the Alzheimer’s Care Pathway of the Future
2
FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection
3
The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 1
4
Current Perspectives on Integrating AI into Radiology
5